{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:21:18Z","timestamp":1788434478163,"version":"build-2803163510"},"reference-count":54,"publisher":"American Chemical Society (ACS)","issue":"34","license":[{"start":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T00:00:00Z","timestamp":1786752000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T00:00:00Z","timestamp":1786752000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T00:00:00Z","timestamp":1786752000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL146153"],"award-info":[{"award-number":["HL146153"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL154154"],"award-info":[{"award-number":["HL154154"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pulmonary hypertension\u2013associated heart failure with preserved ejection fraction (PH-HFpEF) is a prevalent and lethal cardiopulmonary syndrome without effective disease-modifying therapy. We investigated the therapeutic potential of lung spheroid cell\u2013derived exosomes (LSC-Exos) in a murine model of PH-HFpEF induced by high-fat diet feeding. The disease phenotype was validated by echocardiography and histologic assessment. Mice with established PH-HFpEF received daily nebulized LSC-Exo for 3 weeks. Treatment significantly improved right and left ventricular structural parameters, reduced regurgitation velocity, and attenuated pulmonary vascular wall thickening compared with untreated controls. Transcriptomic profiling revealed activation of PI3K-Akt signaling in the lung and suppression of downstream mTOR signaling in the heart following LSC-Exo therapy, with marked upregulation of miR-150-5p in cardiac tissue. To define the mechanistic contribution, diseased mice were treated with miR-150-5p-enriched exosomes or exosomes containing a miR-150-5p inhibitor. miR-150-5p-loaded exosomes recapitulated the majority of functional and structural improvements and modulated mTOR pathway activity, whereas inhibition of miR-150-5p attenuated therapeutic efficacy. No safety concerns were observed. These findings demonstrate that nebulized LSC-Exo therapy ameliorates cardiopulmonary remodeling in PH-HFpEF and identify exosomal miR-150-5p as a key mediator of therapeutic benefit via regulation of PI3K-Akt-mTOR signaling. This study supports the development of inhaled exosome-based therapies for cardiopulmonary vascular disease.<\/jats:p>","DOI":"10.1021\/acsnano.6c06951","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T15:01:59Z","timestamp":1786806119000},"page":"23871-23883","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic Reversal\nof PH-HFpEF via Lung Spheroid\nCell Exosomes"],"prefix":"10.1021","volume":"20","author":[{"given":"Halle J.","family":"Cantor","sequence":"first","affiliation":[{"name":"North Carolina State University , , , ,","place":["Raleigh, North Carolina, United States, 27607"]},{"name":"North Carolina State University , , , ,","place":["Raleigh, North Carolina, United States, 27607"]},{"name":"The University of North Carolina at Chapel Hill and North Carolina State University , , , ,","place":["Raleigh\/Chapel Hill, North Carolina, United States, 27607\/27599"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dashuai","family":"Zhu","sequence":"additional","affiliation":[{"name":"Columbia University , , , ,","place":["New York, New York, United States, 10027"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Li","sequence":"additional","affiliation":[{"name":"North Carolina State University , , , ,","place":["Raleigh, North Carolina, United States, 27607"]},{"name":"The University of North Carolina at Chapel Hill and North Carolina State University , , , ,","place":["Raleigh\/Chapel Hill, North Carolina, United States, 27607\/27599"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Hu","sequence":"additional","affiliation":[{"name":"Columbia University , , , ,","place":["New York, New York, United States, 10027"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen D.","family":"Popowski","sequence":"additional","affiliation":[{"name":"North Carolina State University , , , ,","place":["Raleigh, North Carolina, United States, 27607"]},{"name":"North Carolina State University , , , ,","place":["Raleigh, North Carolina, United States, 27607"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengrui","family":"Liu","sequence":"additional","affiliation":[{"name":"Columbia University , , , ,","place":["New York, New York, United States, 10027"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlang","family":"Li","sequence":"additional","affiliation":[{"name":"The University of North Carolina at Chapel Hill and North Carolina State University , , , ,","place":["Raleigh\/Chapel Hill, North Carolina, United States, 27607\/27599"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nate","family":"Mullens","sequence":"additional","affiliation":[{"name":"The University of North Carolina at Chapel Hill and North Carolina State University , , , ,","place":["Raleigh\/Chapel Hill, North Carolina, United States, 27607\/27599"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Thompson","sequence":"additional","affiliation":[{"name":"The University of North Carolina at Chapel Hill and North Carolina State University , , , ,","place":["Raleigh\/Chapel Hill, North Carolina, United States, 27607\/27599"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Caddell","sequence":"additional","affiliation":[{"name":"The University of North Carolina at Chapel Hill and North Carolina State University , , , ,","place":["Raleigh\/Chapel Hill, North Carolina, United States, 27607\/27599"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Bonagura","sequence":"additional","affiliation":[{"name":"North Carolina State University , , , ,","place":["Raleigh, North Carolina, United States, 27607"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuong-Uyen C.","family":"Dinh","sequence":"additional","affiliation":[{"name":"North Carolina State University , , , ,","place":["Raleigh, North Carolina, United States, 27607"]},{"name":"North Carolina State University , , , ,","place":["Raleigh, North Carolina, United States, 27607"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7082-6893","authenticated-orcid":true,"given":"Ke","family":"Cheng","sequence":"additional","affiliation":[{"name":"Columbia University , , , ,","place":["New York, New York, United States, 10027"]},{"name":"Columbia University , , , ,","place":["New York, New York, United States, 10032"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,8,15]]},"reference":[{"issue":"38","key":"2026090306595971300_cit1","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1093\/eurheartj\/ehw597","article-title":"Pulmonary hypertension in heart failure with preserved ejection fraction:\na plea for proper phenotyping and further research","volume":"38","author":"Hoeper","year":"2016","journal-title":"Eur. Heart J"},{"issue":"5","key":"2026090306595971300_cit2","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jchf.2021.01.015","article-title":"Levosimendan Improves\nHemodynamics and Exercise\nTolerance in PH-HFpEF: Results of the Randomized Placebo-Controlled\nHELP Trial","volume":"9","author":"Burkhoff","year":"2021","journal-title":"JACC Heart Failure"},{"key":"2026090306595971300_cit3","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1161\/CIRCULATIONAHA.119.041886","article-title":"Research\nPriorities\nfor Heart Failure with Preserved Ejection Fraction: National Heart,\nLung, and Blood Institute Working Group Summary","volume":"141","author":"Shah","year":"2020","journal-title":"Circulation"},{"issue":"7","key":"2026090306595971300_cit4","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001079","article-title":"Elucidating the Clinical Implications and Pathophysiology\nof Pulmonary Hypertension in Heart Failure with Preserved Ejection\nFraction: A Call to Action: A Science Advisory from the American Heart\nAssociation","volume":"146","author":"Brittain","year":"2022","journal-title":"Circulation"},{"issue":"3","key":"2026090306595971300_cit5","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1161\/CIRCHEARTFAILURE.110.958801","article-title":"Clinical\ncharacteristics\nof pulmonary hypertension in patients with heart failure and preserved\nejection fraction","volume":"4","author":"Thenappan","year":"2011","journal-title":"Circ.: Heart Failure"},{"issue":"7752","key":"2026090306595971300_cit6","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41586-019-1100-z","article-title":"Nitrosative Stress Drives Heart Failure with Preserved\nEjection Fraction","volume":"568","author":"Schiattarella","year":"2019","journal-title":"Nature"},{"issue":"1","key":"2026090306595971300_cit7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-021-02219-7","article-title":"Identification of heart\nfailure with preserved ejection\nfraction helps risk stratification for hypertrophic cardiomyopathy","volume":"20","author":"Liu","year":"2022","journal-title":"BMC Med"},{"issue":"6","key":"2026090306595971300_cit8","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41569-020-00480-6","article-title":"Cellular and molecular pathobiology\nof heart failure\nwith preserved ejection fraction","volume":"18","author":"Mishra","year":"2021","journal-title":"Nat. Rev.\nCardiol"},{"issue":"2","key":"2026090306595971300_cit9","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1161\/CIRCHEARTFAILURE.113.000823","article-title":"Pulmonary\nhypertension in heart failure preserved ejection fraction: prevalence,\npathophysiology, and clinical perspectives","volume":"7","author":"Guazzi","year":"2014","journal-title":"Circ.: Heart Failure"},{"key":"2026090306595971300_cit10","doi-asserted-by":"publisher","first-page":"4903","DOI":"10.3390\/ijms24054903","article-title":"In Search of the\nHoly Grail: Stem Cell Therapy as a Novel Treatment of Heart Failure\nwith Preserved Ejection Fraction","volume":"24","author":"Domaszk","year":"2023"},{"issue":"12","key":"2026090306595971300_cit11","doi-asserted-by":"publisher","first-page":"12193","DOI":"10.1021\/acsnano.8b05892","article-title":"Pretargeting\nand Bioorthogonal Click Chemistry-Mediated\nEndogenous Stem Cell Homing for Heart Repair","volume":"12","author":"Li","year":"2018","journal-title":"ACS Nano"},{"issue":"5","key":"2026090306595971300_cit12","doi-asserted-by":"publisher","first-page":"7248","DOI":"10.1007\/s12274-023-5374-3","article-title":"Comparison\nof extruded cell nanovesicles and exosomes in their molecular cargos\nand regenerative potentials","volume":"16","author":"Wang","year":"2023","journal-title":"Nano Res"},{"issue":"1","key":"2026090306595971300_cit13","doi-asserted-by":"publisher","first-page":"1785161","DOI":"10.1080\/20013078.2020.1785161","article-title":"Exosome therapeutics for lung regenerative medicine","volume":"9","author":"Popowski","year":"2020","journal-title":"J. Extracell. Vesicles"},{"issue":"1","key":"2026090306595971300_cit14","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/s41467-020-14344-7","article-title":"Inhalation of lung spheroid\ncell secretome and exosomes\npromotes lung repair in pulmonary fibrosis","volume":"11","author":"Dinh","year":"2020","journal-title":"Nat. Commun"},{"issue":"31","key":"2026090306595971300_cit15","doi-asserted-by":"publisher","first-page":"28021","DOI":"10.1021\/acsnano.5c00706","article-title":"Extracellular Vesicles for Clinical Diagnostics: From\nBulk Measurements to Single-Vesicle Analysis","volume":"19","author":"Tran","year":"2025","journal-title":"ACS Nano"},{"issue":"10","key":"2026090306595971300_cit16","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1056\/NEJMra1704286","article-title":"Circulating Extracellular Vesicles\nin Human Disease","volume":"379","author":"Shah","year":"2018","journal-title":"N. Engl. J. Med"},{"key":"2026090306595971300_cit17","doi-asserted-by":"publisher","first-page":"100014","DOI":"10.1016\/j.medidd.2020.100014","article-title":"Cells and cell derivatives as drug\ncarriers for targeted delivery","volume":"3","author":"Lutz","year":"2019","journal-title":"Med. Drug Discovery"},{"issue":"2","key":"2026090306595971300_cit18","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.fmre.2024.03.025","article-title":"Engineering exosomes and exosome-like\nnanovesicles for improving\ntissue targeting and retention","volume":"5","author":"Li","year":"2025","journal-title":"Fundam. Res"},{"key":"2026090306595971300_cit19","doi-asserted-by":"publisher","first-page":"100002","DOI":"10.1016\/j.vesic.2022.100002","article-title":"Inhalable exosomes outperform\nliposomes as mRNA and protein drug carriers to the lung","volume":"1","author":"Popowski","year":"2022","journal-title":"Extracell. Vesicle"},{"issue":"2","key":"2026090306595971300_cit20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41578-025-00841-y","article-title":"Inhalable materials\nand biologics for lung defence and drug delivery","volume":"11","author":"Zhang","year":"2026","journal-title":"Nat. Rev. Mater"},{"issue":"10","key":"2026090306595971300_cit21","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/sctm.16-0374","article-title":"Safety and Efficacy\nof Allogeneic Lung Spheroid Cells\nin a Mismatched Rat Model of Pulmonary Fibrosis","volume":"6","author":"Cores","year":"2017","journal-title":"Stem Cells Transl. Med"},{"key":"2026090306595971300_cit22","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/s41563-023-01475-7","article-title":"An inhaled bioadhesive\nhydrogel to shield non-human primates from SARS-CoV-2 infection","volume":"22","author":"Mei","year":"2023","journal-title":"Nat. Mater"},{"issue":"3","key":"2026090306595971300_cit23","doi-asserted-by":"publisher","first-page":"20200186","DOI":"10.1002\/VIW.20200186","article-title":"Exosome therapeutics\nfor COVID-19 and respiratory viruses","volume":"2","author":"Popowski","year":"2021","journal-title":"View"},{"issue":"6","key":"2026090306595971300_cit24","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jacbts.2017.07.013","article-title":"Murine Models\nof Heart Failure With\nPreserved Ejection Fraction: A \u201cFishing Expedition","volume":"2","author":"Valero-Mun\u0303oz","year":"2017","journal-title":"JACC Basic Transl. Sci"},{"issue":"4","key":"2026090306595971300_cit25","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1165\/rcmb.2016-0177OC","article-title":"Development\nof a mouse model of metabolic syndrome,\npulmonary hypertension, and heart failure with preserved ejection\nfraction","volume":"56","author":"Meng","year":"2017","journal-title":"Am. J. Respir. Cell Mol. Biol"},{"issue":"5","key":"2026090306595971300_cit26","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1159\/000490191","article-title":"Reference ranges and determinants of tricuspid\nregurgitation velocity in healthy adults assessed by two-dimensional\ndoppler-echocardiography","volume":"96","author":"Marra","year":"2018","journal-title":"Respiration"},{"issue":"10","key":"2026090306595971300_cit27","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1161\/CIRCRESAHA.121.318159","article-title":"From Systemic\nInflammation to Myocardial Fibrosis:\nThe Heart Failure with Preserved Ejection Fraction Paradigm Revisited","volume":"128","author":"Paulus","year":"2021","journal-title":"Circ. Res"},{"issue":"6","key":"2026090306595971300_cit28","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1161\/CIRCHEARTFAILURE.109.862664","article-title":"Development of Left Ventricular Diastolic\nDysfunction with Preservation of Ejection Fraction during Progression\nof Infant Right Ventricular Hypertrophy","volume":"2","author":"Kitahori","year":"2009","journal-title":"Circ.:\nHeart Failure"},{"issue":"5","key":"2026090306595971300_cit29","doi-asserted-by":"publisher","first-page":"L882","DOI":"10.1152\/ajplung.00418.2017","article-title":"Surfactant protein C dampens inflammation by decreasing\nJAK\/STAT activation during lung repair","volume":"314","author":"Jin","year":"2018","journal-title":"Am.\nJ. Physiol.: Lung Cell. Mol. Physiol."},{"issue":"9","key":"2026090306595971300_cit30","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1161\/CIRCULATIONAHA.123.065005","article-title":"Inhalable Stem Cell\nExosomes Promote Heart Repair after Myocardial\nInfarction","volume":"150","author":"Li","year":"2024","journal-title":"Circulation"},{"key":"2026090306595971300_cit31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.leukres.2018.09.009","article-title":"Expression of the\nmiR-150 tumor suppressor is restored by and synergizes with rapamycin\nin a human leukemia T-cell line","volume":"74","author":"Podshivalova","year":"2018","journal-title":"Leuk. Res"},{"issue":"9","key":"2026090306595971300_cit32","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1159\/000538670","article-title":"MiR-150\u20135p\nAlleviates Renal Tubule Epithelial\nCell Fibrosis via the Inhibition of Epithelial-Mesenchymal Transition\nby Targeting ZEB1","volume":"185","author":"Zhang","year":"2024","journal-title":"Int. Arch Allergy Immunol"},{"key":"2026090306595971300_cit33","doi-asserted-by":"publisher","first-page":"3023186","DOI":"10.1155\/2020\/3023186","article-title":"Overexpression of\nmiR-150\u20135p Alleviates Apoptosis in Sepsis-Induced Myocardial\nDepression","volume":"2020","author":"Zhu","year":"2020","journal-title":"Biomed. Res. Int"},{"issue":"1","key":"2026090306595971300_cit34","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s11010-025-05417-6","article-title":"MiR-150\u20135p\nattenuates heart failure by targeting MMP14 to regulate vascular smooth\nmuscle cell function","volume":"481","author":"Yu","year":"2026","journal-title":"Mol. Cell. Biochem"},{"key":"2026090306595971300_cit35","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/B978-0-12-409527-4.00003-1","article-title":"Chapter 3 -\nBiology and Diseases of Mice","volume-title":"Laboratory\nAnimal Medicine","author":"Whary","year":"2015","edition":"3rd"},{"issue":"12","key":"2026090306595971300_cit36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113805","article-title":"Allogeneic Cardiospheres Delivered via Percutaneous\nTransendocardial Injection Increase Viable Myocardium, Decrease Scar\nSize, and Attenuate Cardiac Dilatation in Porcine Ischemic Cardiomyopathy","volume":"9","author":"Yee","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"2026090306595971300_cit37","doi-asserted-by":"publisher","first-page":"6309","DOI":"10.1021\/acsbiomaterials.0c00942","article-title":"Cardiac\nStromal Cell Patch Integrated with Engineered\nMicrovessels Improves Recovery from Myocardial Infarction in Rats\nand Pigs","volume":"6","author":"Su","year":"2020","journal-title":"ACS Biomater. Sci. Eng"},{"issue":"6789","key":"2026090306595971300_cit38","doi-asserted-by":"publisher","DOI":"10.1126\/science.adu9394","article-title":"Single\nintramuscular injection of self-amplifying RNA of Nppa to treat myocardial\ninfarction","volume":"391","author":"Zhang","year":"2026","journal-title":"Science"},{"issue":"7","key":"2026090306595971300_cit39","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1161\/CIRCULATIONAHA.106.655209","article-title":"Regenerative potential\nof cardiosphere-derived cells\nexpanded from percutaneous endomyocardial biopsy specimens","volume":"115","author":"Smith","year":"2007","journal-title":"Circulation"},{"issue":"1\u20132","key":"2026090306595971300_cit40","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jacbts.2016.01.003","article-title":"Cardiosphere-Derived\nCells Reverse Heart Failure With\nPreserved Ejection Fraction in Rats by Decreasing Fibrosis and Inflammation","volume":"1","author":"Gallet","year":"2016","journal-title":"JACC Basic Transl. Sci"},{"issue":"1","key":"2026090306595971300_cit41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.52504\/001c.12344","article-title":"Stem Cell Therapies\nand Treatment Advances for Heart Failure with Preserved Ejection Fraction","volume":"4","author":"Soni","year":"2020","journal-title":"Georget Med. Rev"},{"issue":"546","key":"2026090306595971300_cit42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scisignal.aat6409","article-title":"Cells alter\ntheir tRNA abundance to selectively regulate protein synthesis during\nstress conditions","volume":"11","author":"Torrent","year":"2018","journal-title":"Sci. Signaling"},{"issue":"7831","key":"2026090306595971300_cit43","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41586-020-2822-7","article-title":"Capillary\ncell-type\nspecialization in the alveolus","volume":"586","author":"Gillich","year":"2020","journal-title":"Nature"},{"issue":"7","key":"2026090306595971300_cit44","doi-asserted-by":"publisher","first-page":"670","DOI":"10.3390\/biology10070670","article-title":"Pi3k as mediator of apoptosis and contractile dysfunction\nin tgf\u03b21-stimulated cardiomyocytes","volume":"10","author":"Brosinsky","year":"2021","journal-title":"Biology"},{"issue":"6","key":"2026090306595971300_cit45","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/s44161-022-00083-z","article-title":"Human umbilical cord mesenchymal stem\ncell-derived treatment of severe pulmonary arterial hypertension","volume":"1","author":"Hansmann","year":"2022","journal-title":"Nat. Cardiovasc. Res"},{"issue":"July","key":"2026090306595971300_cit46","doi-asserted-by":"publisher","first-page":"110714","DOI":"10.1016\/j.intimp.2023.110714","article-title":"The role of PI3K\/AKT\nsignaling pathway in myocardial ischemia-reperfusion\ninjury","volume":"123","author":"Deng","year":"2023","journal-title":"Int. Immunopharmacol"},{"issue":"18","key":"2026090306595971300_cit47","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.2174\/138161211796390976","article-title":"Phosphoinositide-3 Kinase Signaling\nin Cardiac Hypertrophy\nand Heart Failure","volume":"17","author":"Aoyagi","year":"2011","journal-title":"Curr. Pharm. Des"},{"issue":"August","key":"2026090306595971300_cit48","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3389\/fmed.2020.00425","article-title":"Metformin in Pulmonary Hypertension in Left Heart Disease","volume":"7","author":"Mulkareddy","year":"2020","journal-title":"Front. Med"},{"issue":"2","key":"2026090306595971300_cit49","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1161\/HYPERTENSIONAHA.120.14708","article-title":"mTORC1 (Mechanistic\nTarget of Rapamycin Complex 1) Signaling in Endothelial and Smooth\nMuscle Cells Is Required for Vascular Function","volume":"77","author":"Reho","year":"2021","journal-title":"Hypertension"},{"issue":"4","key":"2026090306595971300_cit50","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.003989","article-title":"Biomarker\nprofiles in\nheart failure patients with preserved and reduced ejection fraction","volume":"6","author":"Tromp","year":"2017","journal-title":"JACC: Heart Failure"},{"key":"2026090306595971300_cit51","doi-asserted-by":"publisher","first-page":"8611","DOI":"10.1182\/blood-2022-171138","article-title":"Clonal Hematopoiesis\nand Heart Failure with Preserved Ejection Fraction","volume":"140","author":"Thomas","year":"2022","journal-title":"Blood"},{"issue":"2","key":"2026090306595971300_cit52","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1161\/CIRCULATIONAHA.118.034271","article-title":"Sex differences\nin cardiovascular pathophysiology why women are overrepresented in\nheart failure with preserved ejection fraction","volume":"138","author":"Beale","year":"2018","journal-title":"Circulation"},{"issue":"21","key":"2026090306595971300_cit53","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1161\/CIRCULATIONAHA.119.042267","article-title":"Female Sex Is Protective in a Preclinical Model\nof Heart Failure with Preserved Ejection Fraction","volume":"140","author":"Tong","year":"2019","journal-title":"Circulation"},{"key":"2026090306595971300_cit54","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1093\/eurheartj\/ehad114","article-title":"Intrapericardial long\nnon-coding RNA\u2013 Tcf21 antisense RNA\ninducing demethylation administration promotes cardiac repair","volume":"44","author":"Zhu","year":"2023","journal-title":"Eur. Heart J"}],"container-title":["ACS Nano"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsnano.6c06951","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/ancac3\/article-pdf\/20\/34\/23871\/66604650\/acsnano.6c06951.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/ancac3\/article-pdf\/20\/34\/23871\/66604650\/acsnano.6c06951.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:00:09Z","timestamp":1788433209000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/ancac3\/article\/20\/34\/23871\/5259309\/Therapeutic-Reversal-of-PH-HFpEF-via-Lung-Spheroid"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,15]]},"references-count":54,"journal-issue":{"issue":"34","published-online":{"date-parts":[[2026,8,15]]},"published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1021\/acsnano.6c06951","relation":{},"ISSN":["1936-0851","1936-086X"],"issn-type":[{"value":"1936-0851","type":"print"},{"value":"1936-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,15]]}}}